Abstract
Metastasis remains the primary cause of cancer patient death. Although the precise molecular mechanisms at play remain largely unknown, tumor progression is currently hypothesized to follow a series of sequential steps known as the metastatic cascade. An important component, thought to be involved early in this cascade, is the process known as epithelial-mesenchymal transition (EMT), whereby epithelial cells undergo morphogenetic alterations and acquire properties typical of mesenchymal cells. EMT confers a metastatic advantage to the cancer cells through the loss of cell-cell adhesion, enhanced proteolytic activity, and increased cell migration and invasiveness. This chapter describes the experimental workflow for the secretome analysis of MDCK cells undergoing oncogenic Ras, and Ras/TGF-β-mediated EMT. To enable this comparison, serum-free cell culture conditions were optimized, and a secretome purification methodology established. Secretome samples were then subjected to DIGE analysis to reveal and quantify proteins that are differentially expressed during EMT. The proteomic strategy detailed within successfully identified several EMT modulators and broadens our understanding of the extracellular facets of the EMT process.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Abbreviations
- 2DE:
-
Two-dimensional gel electrophoresis
- APS:
-
Ammonium persulfate
- BVA:
-
Biological variation analysis
- CM:
-
Conditioned medium
- DIA:
-
Differential in-gel analysis
- DIGE:
-
Two-dimensional fluorescence difference gel electrophoresis
- DMEM:
-
Dulbecco’s Modified Eagle Medium
- DMF:
-
Dimethylformamide
- DTT:
-
Dithiothreitol
- EDA:
-
Extended data analysis
- EMT:
-
Epithelial-mesenchymal transition
- FCS:
-
Fetal calf serum
- LC:
-
Liquid chromatography
- MDCK:
-
Madin Darby canine kidney
- MS:
-
Mass spectrometry
- RT:
-
Room temperature
References
Weigelt B, Peterse JL, and van’t Veer LJ (2005) Breast cancer metastasis: markers and models. Nat Rev Cancer 5:591–602
Chen EI, and Yates JR, 3rd (2007) Cancer proteomics by quantitative shotgun proteomics. Mol Oncol 1:144–159
Chambers AF, Groom AC, and MacDonald IC (2002) Dissemination and growth of cancer cells in metastatic sites. Nat Rev Cancer 2:563–572
Woodhouse EC, Chuaqui RF, and Liotta LA (1997) General mechanisms of metastasis. Cancer 80:1529–1537
Eccles SA, and Welch DR (2007) Metastasis: recent discoveries and novel treatment strategies. Lancet 369:1742–1757
Gupta GP, and Massague J (2006) Cancer metastasis: building a framework. Cell 127:679–695
Christofori G (2006) New signals from the invasive front. Nature 441:444–450
Geiger TR, and Peeper DS (2009) Metastasis mechanisms. Biochim Biophys Acta 1796:293–308
Thiery JP (2002) Epithelial-mesenchymal transitions in tumour progression. Nature Reviews: Cancer 2:442–454
Bonnomet A, Brysse A, Tachsidis A, Waltham M et al (2010) Epithelial-to-mesenchymal transitions and circulating tumor cells. J Mammary Gland Biol Neoplasia 15:261–273
Berx G, Raspe E, Christofori G, Thiery JP et al (2007) Pre-EMTing metastasis? Recapitulation of morphogenetic processes in cancer. Clin Exp Metastasis 24:587–597
Hay ED (1995) An overview of epithelio-mesenchymal transformation. Acta Anat (Basel) 154:8–20
Thiery JP, and Chopin D (1999) Epithelial cell plasticity in development and tumor progression. Cancer Metastasis Rev 18:31–42
Perl AK, Wilgenbus P, Dahl U, Semb H et al (1998) A causal role for E-cadherin in the transition from adenoma to carcinoma. Nature 392:190–193
Mathias RA, Chen YS, Wang B, Ji H et al (2010) Extracellular remodelling during oncogenic Ras-induced epithelial-mesenchymal transition facilitates MDCK cell migration. J Proteome Res 9:1007–1019
Sabbah M, Emami S, Redeuilh G, Julien S et al (2008) Molecular signature and therapeutic perspective of the epithelial-to-mesenchymal transitions in epithelial cancers. Drug Resist Updates 11:123–151
Chen YS, Mathias RA, Mathivanan S, Kapp EA et al (2010) Proteomic profiling of MDCK plasma membranes reveals Wnt-5a involvement during oncogenic H-Ras/TGF-{beta}-mediated epithelial-mesenchymal transition. Mol Cell Proteomics
Spaderna S, Schmalhofer O, Wahlbuhl M, Dimmler A et al (2008) The transcriptional repressor ZEB1 promotes metastasis and loss of cell polarity in cancer. Cancer Res 68:537–544
Vandewalle C, Comijn J, De Craene B, Vermassen P et al (2005) SIP1/ZEB2 induces EMT by repressing genes of different epithelial cell-cell junctions. Nucleic Acids Res 33:6566–6578
Zhang X, Wei D, Yap Y, Li L et al (2007) Mass spectrometry-based “omics” technologies in cancer diagnostics. Mass Spectrom Rev 26:403–431
Walther TC, and Mann M (2010) Mass spectrometry-based proteomics in cell biology. J Cell Biol 190:491–500
Jechlinger M, Grunert S, Tamir IH, Janda E et al (2003) Expression profiling of epithelial plasticity in tumor progression. Oncogene 22:7155–7169
Yang J, Mani SA, Donaher JL, Ramaswamy S et al (2004) Twist, a master regulator of morphogenesis, plays an essential role in tumor metastasis. Cell 117:927–939
Bartel DP (2009) MicroRNAs: target recognition and regulatory functions. Cell 136:215–233
Gregory PA, Bracken CP, Bert AG, and Goodall GJ (2008) MicroRNAs as regulators of epithelial-mesenchymal transition. Cell Cycle 7:3112–3118
Mathias RA, and Simpson RJ (2009) Towards understanding epithelial-mesenchymal transition: a proteomics perspective. Biochim Biophys Acta 1794:1325–1331
Wei J, Xu G, Wu M, Zhang Y et al (2008) Overexpression of vimentin contributes to prostate cancer invasion and metastasis via src regulation. Anticancer Res 28:327–334
Willipinski-Stapelfeldt B, Riethdorf S, Assmann V, Woelfle U et al (2005) Changes in cytoskeletal protein composition indicative of an epithelial-mesenchymal transition in human micrometastatic and primary breast carcinoma cells. Clin Cancer Res 11:8006–8014
Wu L, and Han DK (2006) Overcoming the dynamic range problem in mass spectrometry-based shotgun proteomics. Expert Rev Proteomics 3:611–619
Alban A, David SO, Bjorkesten L, Andersson C et al (2003) A novel experimental design for comparative two-dimensional gel analysis: two-dimensional difference gel electrophoresis incorporating a pooled internal standard. Proteomics 3:36–44
Unlu M, Morgan ME, and Minden JS (1997) Difference gel electrophoresis: a single gel method for detecting changes in protein extracts. Electrophoresis 18:2071–2077
Timms JF, and Cramer R (2008) Difference gel electrophoresis. Proteomics 8:4886–4897
Friedman DB, and Lilley KS (2008) Optimizing the difference gel electrophoresis (DIGE) technology. Methods Mol Biol 428:93–124
Minden J (2007) Comparative proteomics and difference gel electrophoresis. BioTechniques 43:739, 741, 743 passim
Van den Bergh G, and Arckens L (2004) Fluorescent two-dimensional difference gel electrophoresis unveils the potential of gel-based proteomics. Curr Opin Biotechnol 15:38–43
Mathias RA, Wang B, Ji H, Kapp EA et al (2009) Secretome-Based Proteomic Profiling of Ras-Transformed MDCK Cells Reveals Extracellular Modulators of Epithelial-Mesenchymal Transition. J Proteome Res 8:2827–2837
Simpson RJ, Connolly LM, Eddes JS, Pereira JJ et al (2000) Proteomic analysis of the human colon carcinoma cell line (LIM 1215): development of a membrane protein database. Electrophoresis 21:1707–1732
Mosmann T (1983) Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods 65:55–63
Phillips HJ, and Terryberry JE (1957) Counting actively metabolizing tissue cultured cells. Exp Cell Res 13:341–347
Acknowledgments
This work was supported, in part, by the National Health & Medical Research Council of Australia (program grant #487922 (R.J.S)), and funds from the Operational Infrastructure Support Program provided by the Victorian Government of Australia.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2012 Springer Science+Business Media, LLC
About this protocol
Cite this protocol
Mathias, R.A., Ji, H., Simpson, R.J. (2012). Proteomic Profiling of the Epithelial-Mesenchymal Transition Using 2D DIGE. In: Cramer, R., Westermeier, R. (eds) Difference Gel Electrophoresis (DIGE). Methods in Molecular Biology, vol 854. Humana Press. https://doi.org/10.1007/978-1-61779-573-2_19
Download citation
DOI: https://doi.org/10.1007/978-1-61779-573-2_19
Published:
Publisher Name: Humana Press
Print ISBN: 978-1-61779-572-5
Online ISBN: 978-1-61779-573-2
eBook Packages: Springer Protocols